Inhibition of CDK activity and pcna-dependent DNA replication p21 is blocked by interaction with the HPV-16 E7 oncoprotein

Genes and Development

Volumn 11, Issue 16, 1997, Pages 2090-2100

  Funk, Jens Oliver ^a   Waga, Shou ^b   Harry, Jo Beth ^a   Espling, Erik ^a   Stillman, Bruce ^b   Galloway, Denise A ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

^b Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

Author keywords

CDK inhibitors; Cell cycle arrest; DNA replication; HPV 16 E7; HPV 6 E7; p21(CIP1 WAF1 SDI1); PCNA

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN E; CYCLINE; DNA; ONCOPROTEIN; PROTEIN P21; VIRUS PROTEIN;

ARTICLE; CELL CYCLE; CONTROLLED STUDY; DNA DAMAGE; DNA REPLICATION; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; WART VIRUS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES;

EID: 0030827303     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.11.16.2090     Document Type: Article

References (62)

1. cdc2, and this effect is abrogated by adenovirus independently of the E1A-associated pRB binding activity. Mol. Cell Biol. 3: 655-665.
2. Adams, P.D., W.R. Sellers, S.K. Sharma, A.D. Wu, C.M. Nalin, and W.G. Kaelin. 1996. Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors. Mol. Cell. Biol. 16: 6623-6633.
3. 94 → Trp) identified in a human breast carcinoma. Evidence that the mutation impairs the ability of p21 to inhibit cyclin-dependent kinases. J. Biol. Chem. 271: 15782-15786.
4. WAF1. Curr. Biol. 7: 71-80.
5. Blackwood, E.M., B. Lüscher, and R.N. Eisenman. 1992. Myc and Max associate in vivo. Genes & Dev. 6: 71-80.
6. Boyer, S.N., D.E. Wazer, and V. Band. 1996. E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteosome pathway. Cancer Res. 56: 4620-4624.
7. Brugarolas, J., C. Chandrasekaran, J.I. Gordon, D. Beach, T. Jacks, and G.J. Hannon. 1995. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377: 552-557.
8. Chen, J., P.K. Jackson, M.W. Kirschner, and A. Dutta. 1995. Separate domains of p21 involved in the inhibition of cdk kinase and PCNA. Nature 374: 386-388.
9. CIP1. Mol. Cell. Biol. 16: 4673-4682.
10. DeGregori, J., T. Kowalik, and J.R. Nevins. 1995. Cellular targets for activation by the E2F1 transcription factor include DNA synthesis-and G1/S-regulatory genes. Mol. Cell. Biol. 15: 4215-4224.
11. Demers, G.W., S.A. Foster, C.L. Halbert, and D.A. Galloway. 1994. Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7. Proc. Natl. Acad. Sci. 91: 4382-4386.
12. Demers, G.W., E. Espling, J.B. Harry, B.G. Etscheid, and D.A. Galloway. 1996. Abrogation of growth arrest signals by human papillomavirus type 16 E7 is mediated by sequences required for transformation. J. Virol. 70: 6862-6869.
13. CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82: 675-684.
14. Dimri, G.P., M. Nakanishi, P.-Y. Desprez, J.R. Smith, and J. Campisi. 1996. Inhibition of E2F activity by the cyclin-dependent protein kinase inhibitor p21 in cells expressing or lacking a functional retinoblastoma protein. Mol. Cell. Biol. 16: 2987-2997.
15. Dulic, V., W.K. Kaufmann, S.J. Wilson, T.D. Tlsty, E. Lees, J.W. Harper, S.J. Elledge, and S.I. Reed. 1994. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76: 1013-1023.
16. El-Deiry, W.S., T. Tokino, V.E. Velculescu, D.B. Levy, R. Parsons, J.M. Trent, D. Lin, E. Mercer, K.W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825.
17. Flores-Rozas, H., Z. Kelman, F.B. Dean, Z.-Q. Pan, J.W. Harper, S.J. Elledge, M. O'Donnell, and J. Hurvitz. 1994. Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase 5 holoenzyme. Proc. Natl. Acad. Sci. 91: 8655-8659.
18. Gu, Y., C.W. Turck, and D.O. Morgan. 1993. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature 366: 707-710.
19. WAF1/CIP1 complexed with human PCNA. Cell 87: 297-306.
20. Halbert, C.L., G.W. Demers, and D.A. Galloway. 1992. The E6 and E7 genes of human papillomavirus type 6 have weak immortalizing activity in human epithelial cells. J. Virol. 66: 2125-2134.
21. Halevy, O., B.G. Novitch, D.B. Spicer, S.X. Skapek, J. Rhee, G.J. Hannon, D. Beach, and A.B. Lassar. 1995. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267: 1018-1021.
22. Harper, J.W., G.R. Adami, N. Wei, K. Keyomarsi, and S.J. Elledge. 1993. The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816.
23. Harper, J.W., S.J. Elledge, K. Keyomarsi, B. Dynlacht, L.-H. Tsai, P. Zhang, S. Dobrowolski, C. Bai, L. Connel-Crowley, E. Swindell, M.P. Fox, and N. Wei. 1995. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell 6: 387-400.
24. WAF1/CIP1/SDI1. Oncogene 11: 1409-1415.
25. Jones, D.L. and K. Münger. 1997. Analysis of the p53-mediated G1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein. J. Virol. 71: 2905-2912.
26. Waf1/Cip1/Sdi1 in the free and Cdk2-bound state: Conformational disorder mediates binding diversity. Proc. Natl. Acad. Sci. 93: 11504-11509.
27. LaBaer, J., M.D. Garrett, L.F. Stevenson, J.M. Slingerland, C. Sandhu, H.S. Chou, A. Fattaey, and E. Harlow. 1997. New functional activities for the p21 family of CDK inhibitors. Genes & Dev. 11: 847-862.
28. Li, R., S. Waga, G.J. Hannon, D. Beach, and B. Stillman. 1994. Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature 371: 534-537.
29. Li, R., G.J. Hannon, D. Beach, and B. Stillman. 1996. Subcellular distribution of p21 and PCNA in normal and repair-deficient cells following DNA damage. Curr. Biol. 6: 189-199.
30. WAF-1 gene activities. Mol. Cell. Biol. 16: 1786-1793.
31. CIP1. Nature 375: 159-161.
32. Macleod, K.F., N. Sherry, G. Hannon, D. Beach, T. Tokino, K. Kinzler, B. Vogelstein, and T. Jacks. 1995. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes & Dev. 9: 935-944.
33. KIP1 by the viral E1A oncoprotein in TGFβ-treated cells. Nature 380: 262-265.
34. Missero, C., E. Calautti, R. Eckner, J. Chin, L.H. Tsai, D.M. Livingston, and G.P. Dotto. 1995. Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation. Proc. Natl. Acad. Sci. 92: 5451-5455.
35. Morgan, D.O. 1995. Principles of CDK regulation. Nature 374: 131-134.
36. SDI1/WAF1/CIP1 is involved in proliferating cell nuclear antigen binding but does not appear to be required for growth inhibition. J. Biol. Chem. 270: 17060-17063.
37. Noda, A., Y. Ning, S.F. Venable, O.M. Pereira-Smith, and J.R. Smith. 1994. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 211:90-98.
38. Ohtsubo, M., A.M. Theodoras, J. Schumacher, J.M. Roberts, and M. Pagano. 1995. Human cyclin E, a nuclear protein essential for the G1 to S phase transition. Mol. Cell. Biol. 15: 2612-2624.
39. Cip1 in muscle and other terminally differentiating cells. Science 267: 1024-1027.
40. Pietenpol, J.A., R.W. Stein, E. Moran, P. Yaciuk, R. Schlegel, R.M. Lyons, M.R. Pittelkow, K. Münger, P.M. Howley, and H.L. Moses. 1990. TGF-β 1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming protiens with pRB binding domains. Cell 61: 777-785.
41. Podust, V.N., L.M. Podust, F. Goubin, B. Ducommun, and U. Hübscher. 1995. Mechanism of inhibition of proliferating cell nuclear antigen-dependent DNA synthesis by the cyclin-dependent kinase inhibitor p21. Biochemistry 34: 8869-8875.
42. Prelich, G. and B. Stillman. 1988. Coordinated leading and lagging strand synthesis during SV40 DNA replication in vitro requires PCNA. Cell 53: 117-126.
43. Reed, S.I. 1996. Cyclin E: In mid-cycle. Biochim. Biophys. Acta 1287: 151-153.
44. KIP1 cyclin-dependent-kinase inhibitor bound to the cyclin A-cdk2 complex. Nature 382: 325-331.
45. Sherr, C.J. and J.M. Roberts. 1995. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes & Dev. 9: 1149-1163.
46. Shivji, M.K.K., S.J. Grey, U.P. Strausfeld, R.D. Wood, and J.J. Blow. 1994. Cip1 inhibits DNA replication but not PCNA-dependent nucleotide excision-repair. Curr. Biol. 4: 1062-1068.
47. Slebos, R.J.C., M.H. Lee, B.S. Plunkett, T.D. Kessis, B.O. Williams, T. Jacks, L. Hedrick, M.B. Kastan, and K.R. Cho. 1994. p53-dependent G1 arrest involves pRB-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proc. Natl. Acad. Sci. 91: 5320-5324.
48. Stillman, B.W. and Y. Gluzman. 1985. Replication and supercoiling of simian virus 40 DNA in cell extracts from human cells. Mol. Cell. Biol. 5: 2051-2060.
49. XIC1. Proc. Natl. Acad. Sci. 92: 10187-10191.
50. Tsurimoto, T. and B. Stillman. 1991. Replication factors required for SV40 DNA replication in vitro. II. Switching of DNA polymerase a and 8 during initiation of leading and lagging strand synthesis. J. Biol. Chem. 266: 1961-1968.
51. Waga, S., G. Bauer, and B. Stillman. 1994a. Reconstitution of complete SV40 DNA replication with purified replication factors. J. Biol. Chem. 269: 10923-10934.
52. Waga, S., G.J. Hannon, D. Beach, and B. Stillman. 1994b. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369: 574-578.
53. Waldman, T., K.W. Kinzler, and B. Vogelstein. 1995. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res. 55: 5187-5190.
54. Waldman, T., C. Lengauer, K.W. Kinzler, and B. Vogelstein. 1996. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 381: 713-716.
55. WAF1 and proliferating cell nuclear antigen. Curr. Biol. 5: 275-282.
56. Xiong, Y., G.J. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach. 1993a. p21 is a universal inhibitor of cyclin kinases. Nature 366: 701-704.
57. Xiong, Y., H. Zhang, and D. Beach. 1993b. Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes & Dev. 7: 1572-1583.
58. Xiong, Y., D. Kuppuswamy, Y. Li, E.M. Livanos, M. Hixon, A. White, D. Beach, and T.D. Tlsty. 1996. Alteration of cell cycle kinase complexes in human papillomavirus E6-and E7-expressing fibroblasts precedes neoplastic transformation. J. Virol. 70: 999-1008.
59. Zerfass, K., A. Schulze, D. Spitkovsky, V. Friedman, B. Henglein, and P. Jansen-Dürr. 1995. Sequential activation of cyclin E and cyclin A gene expression by human papillomavirus type 16 E7 through sequences necessary for transformation. J. Virol. 69: 6389-6399.
60. KIP1 by the human papillomavirus type 16 E7 oncoprotein. Oncogene 13: 2323-2330.
61. Zhang, H., G.J. Hannon, and D. Beach. 1994. p21-containing cyclin kinases exist in both active and inactive states. Genes & Dev. 8: 1750-1758.
62. zur Hausen, H. 1996. Papillomavirus infections - A major cause of human cancers. Biochim. Biophys. Acta 1288: F55-F78.